Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Nov 15;320(Pt 1):207–214. doi: 10.1042/bj3200207

Characterization of two forms of protein kinase C alpha, with different substrate specificities, from skeletal muscle.

C Schmitz-Peiffer 1, C L Browne 1, T J Biden 1
PMCID: PMC1217919  PMID: 8947489

Abstract

We have investigated protein kinase C (PKC) in skeletal muscle cytosol and demonstrated the presence of two major activities. These did not correspond to different PKC isoenzymes but seemed to represent two species of PKC alpha as deduced by: elution during hydroxyapatite chromatography at KH2PO4 concentrations expected of PKC alpha; detection of the two species by three specific but unrelated anti-(PKC alpha) antibodies; immunodepletion of both activities with anti-(PKC alpha) antibody; and demonstration of identical requirements of both Ca2+ ions and lipid for activation. These species, termed PKC alpha 1 and PKC alpha 2, phosphorylated the modified conventional PKC pseudosubstrate peptide (19-31, Ser-25) equally well. Importantly, however, the activities differed in that PKC alpha 1 phosphorylated histone IIIS, and also peptides derived from the EGF receptor and glycogen synthase, to a much greater extent than did PKC alpha 2. Similarly, incubation of crude muscle extracts with either PKC alpha 1 or alpha 2 gave rise to different protein phosphorylation patterns. The involvement of proteolysis, dephosphorylation or oxidative modification in the interconversion of PKC alpha 1 and PKC alpha 2 during preparation was ruled out. Although some PKC-binding proteins were detected in overlay assays, their presence did not explain the anomalous PKC alpha 2 activity. The results suggest that a modification of PKC alpha in situ limits its substrate specificity, and indicate an additional level of control of the kinase that may be a site for modulation of PKC-mediated signal transduction.

Full Text

The Full Text of this article is available as a PDF (401.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken A., Collinge D. B., van Heusden B. P., Isobe T., Roseboom P. H., Rosenfeld G., Soll J. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci. 1992 Dec;17(12):498–501. doi: 10.1016/0968-0004(92)90339-b. [DOI] [PubMed] [Google Scholar]
  2. Allen B. G., Andrea J. E., Walsh M. P. Identification and characterization of protein kinase C zeta-immunoreactive proteins. J Biol Chem. 1994 Nov 18;269(46):29288–29298. [PubMed] [Google Scholar]
  3. Batlle E., Fabre M., García de Herreros A. Antipeptide antibodies directed against the C-terminus of protein kinase C zeta (PKC zeta) react with a Ca(2+)- and TPA-sensitive PKC in HT-29 human intestinal epithelial cells. FEBS Lett. 1994 May 16;344(2-3):161–165. doi: 10.1016/0014-5793(94)00379-3. [DOI] [PubMed] [Google Scholar]
  4. Borner C., Filipuzzi I., Wartmann M., Eppenberger U., Fabbro D. Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J Biol Chem. 1989 Aug 15;264(23):13902–13909. [PubMed] [Google Scholar]
  5. Cazaubon S., Bornancin F., Parker P. J. Threonine-497 is a critical site for permissive activation of protein kinase C alpha. Biochem J. 1994 Jul 15;301(Pt 2):443–448. doi: 10.1042/bj3010443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapline C., Ramsay K., Klauck T., Jaken S. Interaction cloning of protein kinase C substrates. J Biol Chem. 1993 Apr 5;268(10):6858–6861. [PubMed] [Google Scholar]
  7. Chida K., Kato N., Kuroki T. Down regulation of phorbol diester receptors by proteolytic degradation of protein kinase C in a cultured cell line of fetal rat skin keratinocytes. J Biol Chem. 1986 Oct 5;261(28):13013–13018. [PubMed] [Google Scholar]
  8. Cooper D. R., Watson J. E., Dao M. L. Decreased expression of protein kinase-C alpha, beta, and epsilon in soleus muscle of Zucker obese (fa/fa) rats. Endocrinology. 1993 Nov;133(5):2241–2247. doi: 10.1210/endo.133.5.8404676. [DOI] [PubMed] [Google Scholar]
  9. Dianoux A. C., Stasia M. J., Vignais P. V. Purification and characterization of an isoform of protein kinase C from bovine neutrophils. Biochemistry. 1989 Jan 24;28(2):424–431. doi: 10.1021/bi00428a003. [DOI] [PubMed] [Google Scholar]
  10. Dutil E. M., Keranen L. M., DePaoli-Roach A. A., Newton A. C. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J Biol Chem. 1994 Nov 25;269(47):29359–29362. [PubMed] [Google Scholar]
  11. Fujisawa N., Ogita K., Saito N., Nishizuka Y. Expression of protein kinase C subspecies in rat retina. FEBS Lett. 1992 Sep 14;309(3):409–412. doi: 10.1016/0014-5793(92)80818-2. [DOI] [PubMed] [Google Scholar]
  12. Gopalakrishna R., Anderson W. B. Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6758–6762. doi: 10.1073/pnas.86.17.6758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gopalakrishna R., Anderson W. B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch Biochem Biophys. 1991 Mar;285(2):382–387. doi: 10.1016/0003-9861(91)90377-u. [DOI] [PubMed] [Google Scholar]
  14. Gundimeda U., Hara S. K., Anderson W. B., Gopalakrishna R. Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. Arch Biochem Biophys. 1993 Jan;300(1):526–530. doi: 10.1006/abbi.1993.1072. [DOI] [PubMed] [Google Scholar]
  15. Haleem-Smith H., Chang E. Y., Szallasi Z., Blumberg P. M., Rivera J. Tyrosine phosphorylation of protein kinase C-delta in response to the activation of the high-affinity receptor for immunoglobulin E modifies its substrate recognition. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9112–9116. doi: 10.1073/pnas.92.20.9112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Herbert J. M., Augereau J. M., Gleye J., Maffrand J. P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990 Nov 15;172(3):993–999. doi: 10.1016/0006-291x(90)91544-3. [DOI] [PubMed] [Google Scholar]
  17. Hietanen M., Koistinaho J., Rechardt L., Roivainen R., Pelto-Huikko M. Immunohistochemical evidence for the presence of protein kinase C beta-subtype in rat motoneurons and myoneural junctions. Neurosci Lett. 1990 Jul 31;115(2-3):126–130. doi: 10.1016/0304-3940(90)90442-c. [DOI] [PubMed] [Google Scholar]
  18. Homan E. C., Jensen D. E., Sando J. J. Protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells. J Biol Chem. 1991 Mar 25;266(9):5676–5681. [PubMed] [Google Scholar]
  19. Hong D. H., Huan J., Ou B. R., Yeh J. Y., Saido T. C., Cheeke P. R., Forsberg N. E. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim Biophys Acta. 1995 May 29;1267(1):45–54. doi: 10.1016/0167-4889(95)00024-m. [DOI] [PubMed] [Google Scholar]
  20. House C., Wettenhall R. E., Kemp B. E. The influence of basic residues on the substrate specificity of protein kinase C. J Biol Chem. 1987 Jan 15;262(2):772–777. [PubMed] [Google Scholar]
  21. Kass G. E., Duddy S. K., Orrenius S. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem J. 1989 Jun 1;260(2):499–507. doi: 10.1042/bj2600499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kishimoto A., Kajikawa N., Shiota M., Nishizuka Y. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem. 1983 Jan 25;258(2):1156–1164. [PubMed] [Google Scholar]
  23. Kishimoto A., Mikawa K., Hashimoto K., Yasuda I., Tanaka S., Tominaga M., Kuroda T., Nishizuka Y. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem. 1989 Mar 5;264(7):4088–4092. [PubMed] [Google Scholar]
  24. Kosaka Y., Ogita K., Ase K., Nomura H., Kikkawa U., Nishizuka Y. The heterogeneity of protein kinase C in various rat tissues. Biochem Biophys Res Commun. 1988 Mar 30;151(3):973–981. doi: 10.1016/s0006-291x(88)80461-3. [DOI] [PubMed] [Google Scholar]
  25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  26. Mochly-Rosen D., Khaner H., Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3997–4000. doi: 10.1073/pnas.88.9.3997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mozier N. M., Zürcher-Neely H. A., Guido D. M., Mathews W. R., Heinrikson R. L., Fraser E. D., Walsh M. P., Pearson J. D. Amino acid sequence of a 12-kDa inhibitor of protein kinase C. Eur J Biochem. 1990 Nov 26;194(1):19–23. doi: 10.1111/j.1432-1033.1990.tb19421.x. [DOI] [PubMed] [Google Scholar]
  28. Nakano S., Shimohama S., Saitoh T., Akiguchi I., Kimura J. Localization of protein kinase C in human skeletal muscle. Muscle Nerve. 1992 Apr;15(4):496–499. doi: 10.1002/mus.880150414. [DOI] [PubMed] [Google Scholar]
  29. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992 Oct 23;258(5082):607–614. doi: 10.1126/science.1411571. [DOI] [PubMed] [Google Scholar]
  30. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988 Aug 25;334(6184):661–665. doi: 10.1038/334661a0. [DOI] [PubMed] [Google Scholar]
  31. Ohno S., Konno Y., Akita Y., Yano A., Suzuki K. A point mutation at the putative ATP-binding site of protein kinase C alpha abolishes the kinase activity and renders it down-regulation-insensitive. A molecular link between autophosphorylation and down-regulation. J Biol Chem. 1990 Apr 15;265(11):6296–6300. [PubMed] [Google Scholar]
  32. Osada S., Mizuno K., Saido T. C., Suzuki K., Kuroki T., Ohno S. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol Cell Biol. 1992 Sep;12(9):3930–3938. doi: 10.1128/mcb.12.9.3930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Palumbo E. J., Sweatt J. D., Chen S. J., Klann E. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1439–1445. doi: 10.1016/0006-291x(92)90463-u. [DOI] [PubMed] [Google Scholar]
  34. Pears C., Stabel S., Cazaubon S., Parker P. J. Studies on the phosphorylation of protein kinase C-alpha. Biochem J. 1992 Apr 15;283(Pt 2):515–518. doi: 10.1042/bj2830515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pearson J. D., DeWald D. B., Mathews W. R., Mozier N. M., Zürcher-Neely H. A., Heinrikson R. L., Morris M. A., McCubbin W. D., McDonald J. R., Fraser E. D. Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem. 1990 Mar 15;265(8):4583–4591. [PubMed] [Google Scholar]
  36. Salvatori S., Furlan S., Millikin B., Sabbadini R., Betto R., Margreth A., Salviati G. Localization of protein kinase C in skeletal muscle T-tubule membranes. Biochem Biophys Res Commun. 1993 Nov 15;196(3):1073–1080. doi: 10.1006/bbrc.1993.2360. [DOI] [PubMed] [Google Scholar]
  37. Savart M., Verret C., Dutaud D., Touyarot K., Elamrani N., Ducastaing A. Isolation and identification of a mu-calpain-protein kinase C alpha complex in skeletal muscle. FEBS Lett. 1995 Feb 6;359(1):60–64. doi: 10.1016/0014-5793(95)00014-z. [DOI] [PubMed] [Google Scholar]
  38. Selbie L. A., Schmitz-Peiffer C., Sheng Y., Biden T. J. Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem. 1993 Nov 15;268(32):24296–24302. [PubMed] [Google Scholar]
  39. Shearman M. S., Ogita K., Kikkawa U., Nishizuka Y. A rapid method for the resolution of protein kinase C subspecies from rat brain tissue. Methods Enzymol. 1989;168:347–351. doi: 10.1016/0076-6879(89)68025-1. [DOI] [PubMed] [Google Scholar]
  40. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771–15781. [PubMed] [Google Scholar]
  41. Uehara-Kunugi Y., Shimohama S., Kobayakawa H., Tamura H., Taniguchi T. Different modulation of protein kinase C isozymes in dibutyryl cyclic AMP-differentiated PC12h cells. J Neurochem. 1994 Jul;63(1):125–132. doi: 10.1046/j.1471-4159.1994.63010125.x. [DOI] [PubMed] [Google Scholar]
  42. Yamada K., Avignon A., Standaert M. L., Cooper D. R., Spencer B., Farese R. V. Effects of insulin on the translocation of protein kinase C-theta and other protein kinase C isoforms in rat skeletal muscles. Biochem J. 1995 May 15;308(Pt 1):177–180. doi: 10.1042/bj3080177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Young S., Parker P. J., Ullrich A., Stabel S. Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J. 1987 Jun 15;244(3):775–779. doi: 10.1042/bj2440775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zhang J., Wang L., Schwartz J., Bond R. W., Bishop W. R. Phosphorylation of Thr642 is an early event in the processing of newly synthesized protein kinase C beta 1 and is essential for its activation. J Biol Chem. 1994 Jul 29;269(30):19578–19584. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES